Pharmaceutical agent containing polysaccharide obtained from mycelium of Phellinus linteus against lung cancer

摘要

PURPOSE: A composition containing as an active ingredient, (1,6)-heteroglycan and galactomannoglucan is provided. The composition selectively exhibits cytotoxicity to lung cancer cells and is thus used as a pharmaceutical composition for the treatment of lung cancer. CONSTITUTION: The pharmaceutical composition contains (1,6)-heteroglycan and galactomannoglucan having a molecular weight of 153,000 daltons as immunologically active polysaccharides. The (1,6)-heteroglycan(Mesima) and galactomannoglucan(Mesima PL-2) are obtained by extracting and purifying the mycelium of Phellinus linteus(KCTC 0173BP) and (KCTC 0399BP). The effective dose of the Mesima and Mesima PL-2 is 10 to 25mg/kg.